SIT INVESTMENT ASSOCIATES INC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 769317
Minneapolis, MN
Position in SUPN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,239,421
-$318,143 QoQ
Shares Held
69,650
+1.2% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#82
of 331 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SIT INVESTMENT ASSOCIATES INC holds $4,530,375 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (71.5% of the industry book) .
All Filings in SUPN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,239,421 | 69,650 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,557,564 | 68,825 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,240,440 | 65,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,103,960 | 64,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,047,224 | 64,950 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,270,700 | 38,800 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,403,008 | 38,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,209,784 | 38,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,037,900 | 38,800 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,323,468 | 38,800 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $273,483 | 9,450 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||